Back to Journals » Psychology Research and Behavior Management » Volume 18
Association Between Sleep Duration and Anxiety in US Adults: A Nationally Representative Cross-Sectional Study
Authors Wang X , Zhong Y , Wang R, Zhang D, Li Y , Pan Y, Li Y
Received 7 January 2025
Accepted for publication 10 May 2025
Published 21 May 2025 Volume 2025:18 Pages 1155—1167
DOI https://doi.org/10.2147/PRBM.S516062
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Bao-Liang Zhong
Xing Wang,1 Yunhui Zhong,2 Rui Wang,3 Dongdong Zhang,4 Yihan Li,5 Yi Pan,1 Yibo Li6
1Huzhou Third Municipal Hospital, the Affiliated Hospital of Huzhou University, Huzhou, 313000, People’s Republic of China; 2The Third People’s Hospital of Ganzhou, Ganzhou, 341000, People’s Republic of China; 3Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, 72076, Germany; 4School of Medicine, Xiamen University, Xiamen, 361100, People’s Republic of China; 5Faculty of Health and Wellness, City University of Macau, Macao, 999078, People’s Republic of China; 6Institute of Medical Psychology and Behavioral Neurobiology, University of Tübingen, Tübingen, 72076, Germany
Correspondence: Yibo Li, Email [email protected]
Background: Previous studies on the relationship between sleep duration and anxiety have yielded inconsistent results. This study aimed to explore this association using data from a large, nationally representative sample of US adults.
Methods: Data from 13,476 participants in the National Health and Nutrition Examination Survey (NHANES) 2007– 2012 were analyzed. Weighted robust Poisson regression models were employed to assess the relationship between sleep duration and anxiety, with additional subgroup analyses conducted to explore variations across different demographic groups.
Results: Among participants, 25.8% exhibited symptoms of anxiety. Compared to normal sleep duration (7– 9 hours), very short sleep durations (< 5 hours) and short sleep durations (5 to < 7 hours) were significantly linked to higher anxiety risks, with adjusted incidence rate ratios (IRRs) of 1.40 (95% CI [1.23– 1.59]) and 1.17 (95% CI [1.09– 1.25]), respectively. Subgroup analyses revealed that shorter sleep durations were more strongly associated with anxiety in males, older adults, racial minorities, and married individuals compared to their counterparts. Notably, long sleep duration (≥ 9 hours) showed no significant overall association with anxiety (IRR = 1.11 [0.95– 1.29]); however, in specific subgroups such as non-married individuals and younger adults, it was linked to an increased risk of anxiety.
Conclusion: Short sleep duration is associated with an increased risk of anxiety, with the strength of this association differing notably across demographic subgroups. Long sleep duration is associated with higher anxiety risk exclusively in specific groups, including non-married individuals and younger adults. Further research is needed to uncover the mechanisms underlying these associations.
Keywords: sleep duration, anxiety, NHANES, mental health, cross-sectional study
Graphical Abstract:
Introduction
Anxiety disorders, affecting approximately 34% of the US population, are among the most prevalent mental health issues worldwide.1 These disorders not only cause significant distress and functional impairment but also frequently co-occur with other mental health conditions and a range of physiological disorders, including neurological, cardiovascular, and gastrointestinal diseases.2–6 Given their widespread prevalence and profound impact, it is crucial to investigate the underlying mechanisms of anxiety disorders to develop targeted prevention and intervention strategies.
Sleep is fundamental for cognitive and emotional well-being,7 with disturbances in sleep closely linked to mental health disorders, particularly anxiety.8,9 Recent research has increasingly focused on the relationship between sleep duration and anxiety. A meta-analysis revealed that individuals with anxiety disorders often experience reduced total sleep time.10 Similarly, a cross-sectional survey conducted during the COVID-19 pandemic indicated that non-hospitalized individuals who slept seven or more hours per night exhibited a significantly lower anxiety incidence than those who slept less than seven hours.11 Additionally, a cohort study in Korea found that sleeping between seven to nine hours, as opposed to six hours per day, effectively reduced the likelihood of future anxiety symptoms.12 Furthermore, studies have explored the relationship between short sleep duration and anxiety in specific patient populations, identifying short sleep as a risk factor in patients with stroke,13 gastrointestinal cancers,14 and leukemia.15 However, a two-sample Mendelian randomization study did not support a causal relationship between short sleep duration and anxiety.16 Nonetheless, this type of research has notable limitations. For instance, it relies on limited population groups, which significantly restricts the generalizability of its findings to more diverse populations,17 such as the US population examined in the current study. Therefore, the association between short sleep duration and anxiety warrants further investigation across culturally and demographically diverse populations.
Regarding longer sleep duration, some studies suggest that sleep exceeding nine hours does not increase the risk of anxiety.12 Likewise, the above Mendelian randomization study has not supported a causal relationship between extended sleep duration and anxiety.16 Nevertheless, other research has found that, compared to seven hours or seven to nine hours of sleep, longer sleep duration (≥10 hours) is significantly associated with higher levels of anxiety.18–20 Therefore, the relationship between long sleep duration and anxiety also warrants further exploration.
Notably, existing studies have identified the influence of factors such as age, marital status, and socio-economic status on anxiety within the American population. Anxiety levels among Americans increased significantly over the decade from 2008 to 2018, with the most significant increase in younger adults (18–25 years).21 Compared to peers, individuals who had never been married or had attained higher education levels experienced greater increases in anxiety.21 White, Hispanic/Latino, and Native American individuals have higher rates of anxiety disorder diagnoses compared to Black individuals.22 During the COVID-19 pandemic, individuals from lower socio-economic backgrounds reported greater health and economic concerns, along with higher anxiety levels.23 Furthermore, these demographic factors may also interact with sleep patterns, potentially modifying the relationship between sleep and mental health. For example, adolescents from high-income families experience fewer negative health effects from poor sleep quality.24 Positive parent-child relationships have been shown to amplify the mental health benefits of good sleep.25 Physical activity moderates the relationship between sleep and emotional distress, although this effect was significant only among White populations.26 Additionally, sleep disturbances are common in chronic conditions like diabetes, with research showing that individuals with diabetes who reported short (1–5 h) or long (≥9 h) daily sleep were more likely to report serious psychological distress than individuals who slept 6–8 hours a day.27 Therefore, when exploring the relationship between sleep duration and anxiety, it is essential to account for the influence of demographic variables, lifestyle factors, and overall health status.
Although prior studies have examined the association between sleep duration and anxiety, findings have been inconsistent. More importantly, few have systematically investigated how this relationship varies across sociodemographic subgroups using nationally representative data from the United States. This study utilizes data from the National Health and Nutrition Examination Survey (NHANES), a robust and nationally representative dataset renowned for its rigorous sampling methodology, which ensures that the findings can be generalized to the broader US population. The study aims to achieve two primary objectives: first, to explore the association between sleep duration and anxiety within a representative population, and second, to examine how this relationship varies across different demographic subgroups. Understanding these relationships is essential for deepening our knowledge of the complex interplay between sleep and anxiety and for guiding targeted public health interventions.
Materials and Methods
Study Population
The NHANES is a comprehensive research program designed to assess the health and nutritional status of adults and children across the United States. The NHANES protocol was approved by the Ethics Review Board of the National Center for Health Statistics, ensuring the ethical treatment of all participants. Each participant provided written informed consent. The dataset used in this study is publicly available and fully anonymized in accordance with NHANES policies. In accordance with Items 1 and 2 of Article 32 of the Measures for Ethical Review of Life Science and Medical Research Involving Human Subjects (issued February 18, 2023, China), research that (1) utilizes legally obtained, publicly available data, or data collected through non-interventional public observation, and (2) involves anonymized information, does not require separate Institutional Review Board (IRB) approval under Chinese national legislation. This cross-sectional study utilized data from three NHANES cycles conducted between 2007 and 2012. The initial sample included 30,442 participants, but exclusion criteria were applied to refine the study population. Participants were excluded if they were under 20 years of age, had incomplete data on key variables such as anxiety or sleep duration, or lacked information on critical covariates, including age, sex, race, education, marital status, poverty income ratio (PIR), body mass index (BMI), smoking status, alcohol consumption, physical activity, hypertension, diabetes, and depression and sedative-hypnotic drugs. After applying these criteria, the final sample comprised 13,476 subjects (see Figure 1).
![]() |
Figure 1 Flowchart of participants inclusion and exclusion. Abbreviations: BMI, body mass index; PIR, poverty-to-income ratio. |
Assessment of Anxiety
Anxiety in the NHANES 2007–2012 study was assessed using a self-report question: “During the past 30 days, for about how many days have you felt worried, tense, or anxious?” Detailed information about this anxiety measure is available on the NHANES website (https://wwwn.cdc.gov/Nchs/Nhanes/2007-2008/HSQ_E.htm). Consistent with previous studies,28–31 anxiety status was classified as “no” (felt anxious for 0–6 days per month) or “yes” (felt anxious for 7–30 days per month).
Assessment of Sleep Duration
Sleep duration in the NHANES 2007–2012 study was assessed through self-reporting. Participants were asked: “How much sleep do you usually get at night on weekdays or workdays?” Detailed information about this sleep measure is available on the NHANES website (https://wwwn.cdc.gov/Nchs/Nhanes/2007-2008/SLQ_E.htm). Based on their responses, sleep duration was classified into four categories: less than 5 hours (very short), 5 to less than 7 hours (short), 7 to less than 9 hours (normal), and 9 hours or more (long).32
Assessment of Covariates
Covariate data were meticulously gathered, segmented by diverse demographic factors such as sex (female, male), age categories (20–39, 40–59, ≥60), race/ethnicity (Mexican American, other Hispanic, non-Hispanic White, non-Hispanic Black, other races), educational attainment (below high school, high school graduate, post-high school), marital status (married, separated/divorced/widowed, never married), and poverty income ratio (PIR) classified into ≤130%, 130–350%, and >350%. Participants’ smoking and drinking behaviors were categorized into never, former, and current based on their responses to self-administered questionnaires. Individuals who had never smoked 100 cigarettes were labeled as never smokers, those who had smoked at least 100 cigarettes and continued to smoke were designated as current smokers, while former smokers had a history of smoking 100 cigarettes but had since ceased.33 In terms of alcohol consumption, never drinkers had ingested fewer than 12 alcoholic beverages in their lifetime, former drinkers had consumed at least 12 drinks but abstained in the past year, and current drinkers had both consumed at least 12 drinks and had alcohol intake within the last year.34 Body mass index (BMI) was stratified into four distinct categories based on physical examination results: underweight (<18.5 kg/m²), normal weight (18.5–24.9 kg/m²), overweight (25–29.9 kg/m²), and obese (≥30 kg/m²).35 Physical activity (PA) was assessed using the Metabolic Equivalent of Task (MET), a standardized measure that evaluates energy expenditure relative to resting metabolic rate and functions as a key marker of exercise intensity.36 Data were gathered through the Global Physical Activity Questionnaire (GPAQ), with MET values assigned in accordance with NHANES guidelines. Vigorous activities, including both work-related and leisure-time activities, were assigned a MET value of 8.0. Moderate activities, such as work-related tasks, leisure-time activities, and transportation-related tasks like walking or cycling, were assigned a MET value of 4.0. Weekly MET minutes (MET-min/week) were computed by multiplying the MET value for each activity by its weekly frequency and session duration (in minutes), then summing these across all activity types.37,38 According to the Physical Activity Guidelines for Americans,39 PA levels were divided into four categories: High-Level Physical Activity (HLPA), defined as >1200 MET-min/week; Moderate-Level Physical Activity (MLPA), covering 600 to 1200 MET-min/week; Low-Level Physical Activity (LLPA), ranging from 1 to 599 MET-min/week; and No Physical Activity (No-PA), corresponding to 0 MET-min/week. Blood pressure readings were taken up to four consecutive times by trained professionals, with the average of a minimum of three measurements determining both systolic blood pressure (SBP) and diastolic blood pressure (DBP). Hypertension was identified if participants met any of the following: a self-reported diagnosis by a healthcare provider, ongoing use of antihypertensive drugs, or an average SBP of 140 mmHg or higher, or an average DBP of 90 mmHg or higher during the examination.28,33 Diabetic status was established based on whether participants had been previously diagnosed, were currently using insulin, or were taking other diabetes-related medications.40 Depressive symptoms were evaluated using the Patient Health Questionnaire (PHQ-9), with scores of 10 or above indicating the presence of depression.41 Participants were asked whether they had used any prescription medications in the past month and, if so, to specify the names of the drugs. This information was used to identify sedative-hypnotic medications, including chlordiazepoxide, clonazepam, oxazepam, flurazepam, estazolam, alprazolam, clorazepate, lorazepam, diazepam, temazepam, triazolam, zolpidem, eszopiclone, and zaleplon.42
Statistical Analysis
Unweighted frequencies and weighted percentages were used to describe the categorical variables, ensuring population-representative characteristics. Weighted Chi-squared tests were performed to assess differences between anxiety groups. Weighted Robust Poisson regression was applied to estimate incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for the association between sleep duration and anxiety. Given that over 25% of participants reported anxiety symptoms, logistic regression, which estimates odds ratios, may overstate relative risks, leading to potential misinterpretation. In contrast, robust Poisson regression directly estimates IRRs, offering a more accurate and interpretable measure, particularly when the event rate exceeds 15%, as in this study. By using a sandwich estimator, this method also addresses overdispersion in standard Poisson regression, ensuring stable and reliable estimates. Therefore, robust Poisson regression was preferred over logistic regression or standard Poisson regression due to its suitability for handling high event rates and providing more reliable estimates. Three models were constructed for the analysis: Model 1 with no adjustments; Model 2 adjusted for sex, age, race, education level, marital status, PIR, and BMI; and Model 3 adjusted for sex, age, race, education level, marital status, PIR, BMI, smoking status, drinking status, physical activity, hypertension, diabetes, depression and sedative-hypnotic drugs. Subgroup analyses were performed to evaluate potential effect modification by sex, age, race, education level, marital status, and PIR. All statistical analyses were performed using EmpowerStats (http://www.empowerstats.com) and R software version 4.3.2 (https://www.r-project.org/). A two-sided p-value of <0.05 was considered statistically significant.
Results
The analysis included a total of 13,476 participants, of whom 10,005 (74.2%) did not exhibit anxiety symptoms, while 3471 (25.8%) presented with anxiety symptoms. Table 1 summarizes the general characteristics of the study population, stratified by the presence or absence of anxiety symptoms. Notably, sleep duration differed clearly and significantly between the two groups (P < 0.001). Additionally, several variables, including age, sex, race, education level, marital status, PIR, smoking status, drinking status, BMI, physical activity, depression, and the use of hypnotics, were all significantly associated with anxiety symptoms.
![]() |
Table 1 Sample Characteristics, Overall and Stratified by Anxiety Status |
Table 2 presents the association between sleep duration and anxiety, with IRRs and 95% CIs provided for short sleep durations (<5 hours and 5–7 hours) and long sleep durations (≥9 hours) compared to the mid-range category (7–9 hours). In the unadjusted model (Model 1), participants with less than 5 hours of sleep had a 138% higher risk of anxiety symptoms (IRR = 2.38, 95% CI [2.09, 2.70]), and those sleeping 5–7 hours had a 30% higher risk (IRR = 1.30, 95% CI [1.21, 1.40]). Long sleep durations (≥9 hours) were also associated with a 26% higher risk (IRR = 1.26, 95% CI [1.08, 1.48]). After adjusting for demographic and socioeconomic factors (Model 2), the increased risk of anxiety symptoms remained significant for participants sleeping less than 5 hours (IRR = 2.16, 95% CI [1.91, 2.45]) and 5–7 hours (IRR = 1.28, 95% CI [1.19, 1.37]), while the risk for long sleep durations (≥9 hours) decreased slightly but remained statistically significant (IRR = 1.23, 95% CI [1.05, 1.43]). In the fully adjusted model (Model 3), which included additional lifestyle and health-related factors, the risk associated with less than 5 hours of sleep was reduced but remained significant at 40% (IRR = 1.40, 95% CI [1.23, 1.59]), while the risk for 5–7 hours of sleep persisted at 17% (IRR = 1.17, 95% CI [1.09, 1.25]). The association between long sleep durations (≥9 hours) and anxiety symptoms, however, was no longer statistically significant in this model (IRR = 1.11, 95% CI [0.95, 1.29]).
![]() |
Table 2 Weighted Robust Poisson Regression Analysis of the Association Between Sleep Duration and Anxiety |
As shown in Table 3, the association between sleep duration and anxiety varied significantly across demographic subgroups. Among males, very short sleep durations (<5 hours) were strongly associated with a higher anxiety risk (IRR = 1.59 [1.29–1.95]) compared to females (IRR = 1.24 [1.10–1.41]). Short sleep durations (5 to <7 hours) also showed significant associations in both groups, with slightly stronger effects in males (IRR = 1.23 [1.08–1.40]) than in females (IRR = 1.10 [1.01–1.20]). For age, older adults (≥60 years) exhibited greater sensitivity to both very short (IRR = 1.46 [1.15–1.86]) and short sleep durations (IRR = 1.35 [1.15–1.58]) compared to younger adults (<60 years; very short: IRR = 1.38 [1.21–1.56]; short: IRR = 1.12 [1.04–1.21]). Regarding race, racial minorities experienced stronger associations with very short (IRR = 1.39 [1.23–1.57]) and short sleep durations (IRR = 1.20 [1.08–1.34]) compared to Non-Hispanic White individuals (very short: IRR = 1.37 [1.17–1.60]; short: IRR = 1.14 [1.04–1.24]). Marital status further modulated the relationship between short sleep duration and anxiety, with married individuals showing higher anxiety risks associated with very short sleep durations (IRR = 1.47 [1.22–1.77]) than their non-married counterparts (IRR = 1.29 [1.10–1.51]). Notably, long sleep durations (≥9 hours) were generally not significantly associated with anxiety, except in younger adults and non-married individuals, where increased risks were observed.
![]() |
Table 3 Subgroup Analyses for the Effect of Sleep Duration on Anxiety Risk |
Discussion
This study, utilizing data from a nationally representative sample of 13,476 US participants from NHANES, demonstrates a clear association between short sleep duration and increased anxiety risk compared to the recommended 7 to 9 hours of sleep. Both very short sleep duration (<5 hours) and short sleep duration (5 to <7 hours) were independently associated with higher anxiety symptoms, even after adjusting for demographic, lifestyle, and health-related factors. Subgroup analyses revealed that males, older adults, racial minorities, and married individuals exhibited greater sensitivity to the adverse effects of short sleep duration on anxiety. Extended sleep duration (≥9 hours) was typically not associated with anxiety symptoms, but in certain subgroups, such as younger adults and non-married individuals, it was found to elevate the risk of anxiety.
Our findings of a significant association between short sleep duration and anxiety align with previous research.10–15,43–45 Several mechanisms may underlie this observed relationship. The predominant theory suggests that inadequate sleep impairs brain regions responsible for emotional regulation,46 a dysfunction commonly observed in individuals with anxiety. Specifically, insufficient sleep increases the amygdala’s reactivity to negative stimuli.47 Research has shown that decreased functional connectivity between the medial prefrontal cortex (mPFC) and the amygdala occurs following total sleep deprivation, five nights of partial sleep restriction (four hours per night), or in individuals who habitually sleep less than 6.5 hours per night.47–49 This suggests that the heightened reactivity of the amygdala may result from diminished regulatory control by the mPFC. Moreover, short sleep duration has been linked to dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to increased cortisol secretion,50 which is strongly associated with anxiety disorders.51 Additionally, insufficient sleep has been connected to heightened systemic inflammation,52 a factor that may contribute to the development of anxiety.53 The combined effects of these physiological changes may help explain the increased risk of anxiety observed in individuals with shorter sleep durations. However, a previous Mendelian randomization study found no causal association between short sleep duration and anxiety,16 which contrasts with our findings. The observed discrepancy may arise from the fact that Mendelian randomization studies predominantly reflect limited population groups, which greatly limits the applicability of their findings to more diverse groups,17 such as the US population analyzed in this study. Future research should aim to include more diverse cohorts to more accurately examine the relationship between sleep duration and anxiety. Additionally, combining genetic approaches with observational studies could provide a more comprehensive understanding of this association.
Our overall analysis did not find an association between long sleep duration and anxiety, which is consistent with some previous studies.12,16 However, other research has identified a significant link between the two.18–20 Prather et al found that individuals with longer sleep durations had elevated levels of interleukin-6 and C-reactive protein, suggesting that increased inflammatory cytokines may be a mechanism linking longer sleep with various health conditions.54 Although there is evidence indicating the impact of inflammation on anxiety,55 further research is needed to explore this relationship in greater detail.
Our study adds to the existing evidence by highlighting variations in the association between sleep duration and anxiety across demographic subgroups. Notably, our findings show that males may be particularly sensitive to the effects of short sleep on anxiety. While short sleep impairs cognitive and executive functioning in both males and females, males’ achievement-oriented tendencies may amplify the psychological impacts of these impairments, potentially increasing their susceptibility to anxiety.56,57 Furthermore, insufficient sleep, particularly reduced slow-wave sleep, has been linked to lower testosterone levels,58,59 which are associated with heightened anxiety.60,61 Together, these findings suggest that males may experience heightened anxiety due to a combination of psychological and physiological vulnerabilities associated with short sleep.
Additionally, our findings indicate that older adults (aged 60 and above) are particularly vulnerable to the negative effects of short sleep on anxiety, likely due to age-related declines in sleep quality. With advancing age, individuals often experience more frequent sleep disruptions and reduced slow-wave sleep, both essential for restorative rest.62,63 Studies have also linked declines in rapid eye movement sleep to impaired regulation of negative emotions, a more pronounced relationship in older adults.64,65 In addition to these physiological changes, older individuals may face shifts in social roles, reduced social support, and heightened feelings of loneliness, all of which are strongly associated with anxiety and other negative emotional states.66,67 These physiological and social factors together may exacerbate the detrimental effects of insufficient sleep, increasing anxiety vulnerability among older adults. By comparison, a significant association between long sleep duration and anxiety is observed primarily in younger individuals. In younger participants, long sleep is associated with elevated levels of inflammatory markers, such as interleukin-6 and C-reactive protein,54,68 which have been linked to increased anxiety risk.55 However, in older adults, who often have higher baseline levels of chronic inflammation,69 this pre-existing state may dampen their physiological sensitivity to additional inflammatory triggers, such as long sleep duration, making the impact less pronounced.
It is worth noting that in the age subgroup analysis, 7 to 9 hours of sleep was uniformly defined as the reference range for all age groups (< 60 years and ≥ 60 years). While this aligns with general sleep guidelines, existing literature presents mixed conclusions about changes in sleep needs with age. Previous research suggest that older adults generally sleep less than younger individuals due to changes in sleep architecture.70 However, our data showed that older adults reported an average sleep duration of 6.94 hours (SD = 1.49), which was slightly longer than the 6.75 hours (SD = 1.40) observed among younger adults, a statistically significant difference (t = 7.11, df = 13,474, p < 0.001). These findings are consistent with some studies suggesting that older adults may require similar or even slightly more sleep than younger individuals,71,72 challenging the view that sleep needs decline with age. Future studies should focus on developing age-specific sleep reference ranges to better capture older adults’ unique sleep characteristics and health outcomes.
Our study also revealed significant racial disparities, with non-majority racial groups in the US showing a higher risk of anxiety linked to short sleep duration. Previous research has suggested that racial and ethnic minorities, as well as socioeconomically disadvantaged groups, are more likely to experience sleep patterns associated with adverse health outcomes.73 This elevated risk may be partly due to chronic stressors, such as cultural attitudes and discrimination, which minority groups are more likely to face. One study found that individuals from minority groups who experienced discrimination during the day were more likely to report sleep disturbances that night.74 Moreover, these individuals may encounter additional stressors, including low-income challenges, poor housing and community environments, and inadequate social support systems,75–78 which may further amplify the relationship between short sleep duration and anxiety.
Furthermore, a significant link between short sleep duration and anxiety was evident in both married and unmarried groups, with the connection notably stronger among married individuals. Married individuals, especially those with children, tend to shoulder greater family responsibilities and caregiving duties,79 and insufficient sleep can impair their ability to regulate negative emotions, leading to a notable increase in anxiety levels. Additionally, differences in sleep habits or schedules between partners can adversely affect sleep quality.80,81 Interestingly, unmarried individuals further exhibited the effects of long sleep duration on anxiety. A possible explanation is that unmarried individuals may experience a lack of social support and more irregular lifestyles. Longer sleep duration in this group could reflect inconsistent daily rhythms and a diminished sense of purpose, both of which are strongly associated with anxiety. However, this interpretation requires further exploration in future studies.
This study benefits from the use of NHANES data, providing a large, nationally representative sample and ensuring robust results through adjustments for demographic, lifestyle, and health factors. The analysis of sex, age, race, and marital status subgroups offers new insights into how sleep duration affects anxiety across different demographics. However, this study also has several limitations that should be acknowledged. First, its cross-sectional design precludes the ability to establish causal relationships between sleep duration and anxiety symptoms. Second, both sleep duration and anxiety were assessed using single self-reported items. While these methods are widely used in large-scale epidemiological surveys due to their feasibility and low respondent burden, they are inherently limited in their ability to capture important dimensions such as sleep quality, variability, and disturbances. In addition, self-reported measures are subject to individual misperceptions, particularly in estimating sleep duration. Furthermore, anxiety symptoms often co-occur with other mental health conditions, making it difficult to isolate their independent association with sleep patterns.
Future research should incorporate more comprehensive and objective assessments, such as actigraphy or polysomnography, to improve the accuracy of sleep measurement and validate the current findings. It is also important to consider other potentially influential factors, such as disrupted sleep patterns, elevated stress levels, interference with social and occupational functioning, and underlying or ongoing health conditions, which may mediate or confound the observed associations. In addition, future studies could explore differences in sleep patterns between workdays and weekends, as such variations may offer further insight into the relationship between sleep duration and anxiety, and help inform more targeted intervention strategies.
Conclusions
Findings from this study suggest a potential association between short sleep duration and an increased risk of anxiety symptoms, particularly among males, older adults, racial minorities, and married individuals. In contrast, long sleep duration may be linked to increased anxiety risk only in certain populations, such as younger adults and non-married individuals. These associations should be interpreted with caution due to limitations in the measurement of sleep and anxiety. Further investigation is needed to unravel the mechanisms underlying these associations and inform tailored interventions’ design.
Data Sharing Statement
The data utilized in this study are publicly accessible at the following link: https://wwwn.cdc.gov/nchs/nhanes/default.aspx.
Ethics Approval and Consent to Participate
The NHANES protocol was approved by the Ethics Review Board of the National Center for Health Statistics, ensuring the ethical treatment of all participants. Each participant provided written informed consent.
Acknowledgments
We would like to express our gratitude to the participants of the NHANES. Additionally, we extend our thanks to the US Centers for Disease Control and Prevention (CDC) for making the data publicly available.
Author Contributions
All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.
Funding
This study was not supported by any funding.
Disclosure
The authors declare there are no competing interests.
References
1. Szuhany KL, Simon NM. Anxiety disorders: a review. JAMA. 2022;328(24):2431–2445. doi:10.1001/jama.2022.22744
2. Aquin JP, El-Gabalawy R, Sala T, Sareen J. Anxiety disorders and general medical conditions: current research and future directions. Focus. 2017;15(2):173–181. doi:10.1176/appi.focus.20160044
3. Essau CA, Lewinsohn PM, Lim JX, Ho M-HR, Rohde P. Incidence, recurrence and comorbidity of anxiety disorders in four major developmental stages. J Affect Disord. 2018;228:248–253. doi:10.1016/j.jad.2017.12.014
4. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(8):807–816. doi:10.1001/archpsyc.61.8.807
5. Lim L-F, Solmi M, Cortese S. Association between anxiety and hypertension in adults: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;131:96–119. doi:10.1016/j.neubiorev.2021.08.031
6. Sareen J, Cox BJ, Clara I, Asmundson GJG. The relationship between anxiety disorders and physical disorders in the U.S. national comorbidity survey. Depress Anxiety. 2005;21(4):193–202. doi:10.1002/da.20072
7. Goldstein AN, Walker MP. The role of sleep in emotional brain function. Annu Rev Clin Psychol. 2014;10(1):679–708. doi:10.1146/annurev-clinpsy-032813-153716
8. Freeman D, Sheaves B, Waite F, Harvey AG, Harrison PJ. Sleep disturbance and psychiatric disorders. Lancet Psychiatry. 2020;7(7):628–637. doi:10.1016/S2215-0366(20)30136-X
9. Hertenstein E, Feige B, Gmeiner T, et al. Insomnia as a predictor of mental disorders: a systematic review and meta-analysis. Sleep Med Rev. 2019;43:96–105. doi:10.1016/j.smrv.2018.10.006
10. Cox RC, Olatunji BO. Sleep in the anxiety-related disorders: a meta-analysis of subjective and objective research. Sleep Med Rev. 2020;51:101282. doi:10.1016/j.smrv.2020.101282
11. Zhang Y, Ma J, Xu Q, et al. Effects of sleep duration, perceived organisational support and personal resilience on anxiety in non-hospitalised residents during the COVID-19 pandemic: a survey study in Ningbo, China. BMJ Open. 2023;13(8):e073648. doi:10.1136/bmjopen-2023-073648
12. Kim S-Y, Shin Y-C, Oh K-S, et al. The association of occupational stress and sleep duration with anxiety symptoms among healthy employees: a cohort study. Stress Health. 2020;36(5):675–685. doi:10.1002/smi.2948
13. Liu F, Yang Y, Wang S, et al. Impact of sleep duration on depression and anxiety after acute ischemic stroke. Front Neurol. 2021;12:630638. doi:10.3389/fneur.2021.630638
14. de Sousa DE, de Carli MN, Fernandes RC, et al. Are depression and anxiety disorders associated with adductor pollicis muscle thickness, sleep duration, and protein intake in cancer patients? Exp Gerontol. 2020;130:110803. doi:10.1016/j.exger.2019.110803
15. Huan Y, Mujun X, Xin L, et al. Short sleep duration as a risk factor for depression, anxiety and fatigue in patients with leukemia. Neuropsychiatr Dis Treat. 2022;18:1573–1582. doi:10.2147/NDT.S362229
16. Zhou F, Li S, Xu H. Insomnia, sleep duration, and risk of anxiety: a two-sample Mendelian randomization study. J Psychiatr Res. 2022;155:219–225. doi:10.1016/j.jpsychires.2022.08.012
17. Fatumo S, Chikowore T, Choudhury A, et al. A roadmap to increase diversity in genomic studies. Nat Med. 2022;28(2):243–250. doi:10.1038/s41591-021-01672-4
18. van Mill JG, Hoogendijk WJG, Vogelzangs N, van Dyck R, Penninx BWJH. Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders. J Clin Psychiatry. 2010;71(03):239–246. doi:10.4088/JCP.09m05218gry
19. van Mill JG, Vogelzangs N, van Someren EJW, Hoogendijk WJG, Penninx BWJH. Sleep duration, but not insomnia, predicts the 2-year course of depressive and anxiety disorders. J Clin Psychiatry. 2014;75(02):119–126. doi:10.4088/JCP.12m08047
20. Zhou L, Zhang H, Luo Z, et al. Abnormal night sleep duration and inappropriate sleep initiation time are associated with elevated anxiety symptoms in Chinese rural adults: the Henan rural cohort. Psychiatry Res. 2020;291:113232. doi:10.1016/j.psychres.2020.113232
21. Goodwin RD, Weinberger AH, Kim JH, Wu M, Galea S. Trends in anxiety among adults in the United States, 2008-2018: rapid increases among young adults. J Psychiatr Res. 2020;130:441–446. doi:10.1016/j.jpsychires.2020.08.014
22. Vanderminden J, Esala JJ. Beyond symptoms: race and gender predict anxiety disorder diagnosis. Soc Mental Health. 2019;9(1):111–125. doi:10.1177/2156869318811435
23. Cozen AE, Carton T, Hamad R, et al. Factors associated with anxiety during the first two years of the COVID-19 pandemic in the United States: an analysis of the COVID-19 citizen science study. PLoS One. 2024;19(2):e0297922. doi:10.1371/journal.pone.0297922
24. Gillis BT, McWood LM, Brigham EF, Hinnant JB, El-Sheikh M. Family income as a moderator of relations between sleep and physical health during adolescence. Sleep Health. 2023;9(6):868–875. doi:10.1016/j.sleh.2023.09.009
25. So M, Perry NB, Langenfeld AD, Barnes AJ. Adolescent sleep and mental health across race/ethnicity: does parent-child connectedness matter? J Dev Behav Pediatr. 2021;42(9):742–750. doi:10.1097/DBP.0000000000000958
26. Moore J, Richards S, Popp C, et al. The moderating effect of physical activity on the relationship between sleep and emotional distress and the difference between blacks and whites: a secondary data analysis using the national health interview survey from 2005-2015. Int J Environ Res Public Health. 2021;18(4):1718. doi:10.3390/ijerph18041718
27. Huang Y-C, Zuñiga JA, García AA. Association between sleep and serious psychological distress in patients with diabetes. Psychol Health Med. 2019;24(8):925–935. doi:10.1080/13548506.2019.1612075
28. Chen K, Tan M, Li Y, Song S, Meng X. Association of blood metals with anxiety among adults: a nationally representative cross-sectional study. J Affect Disord. 2024;351:948–955. doi:10.1016/j.jad.2024.02.026
29. Dantzer JA, Keet CA. Anxiety associated with food allergy in adults and adolescents: an analysis of data from the national health and nutrition examination survey (NHANES) 2007-2010. J Allergy Clin Immunol Pract. 2020;8(5):1743–1746.e5. doi:10.1016/j.jaip.2019.12.028
30. Gui J, Ding R, Huang D, et al. Associations between urinary heavy metals and anxiety among adults in the national health and nutrition examination survey (NHANES), 2007-2012. Chemosphere. 2023;341:140085. doi:10.1016/j.chemosphere.2023.140085
31. Wen Z, Bai L, Wu S, et al. Association of serum vitamin D with anxiety in US adults: a cross-sectional study. Front Nutr. 2024;11:1371170. doi:10.3389/fnut.2024.1371170
32. Cai Y, Zhaoxiong Y, Zhu W, Wang H. Association between sleep duration, depression and breast cancer in the United States: a national health and nutrition examination survey analysis 2009-2018. Ann Med. 2024;56(1):2314235. doi:10.1080/07853890.2024.2314235
33. Wang X, Sun M, Wang L, et al. The role of dietary inflammatory index and physical activity in depressive symptoms: results from NHANES 2007-2016. J Affect Disord. 2023;335:332–339. doi:10.1016/j.jad.2023.05.012
34. Cepeda MS, Kern DM, Blacketer C, Drevets WC. Low levels of cholesterol and the cholesterol type are not associated with depression: results of a cross-sectional NHANES study. J Clin Lipidol. 2020;14(4):515–521. doi:10.1016/j.jacl.2020.06.001
35. Adjibade M, Andreeva VA, Lemogne C, et al. The inflammatory potential of the diet is associated with depressive symptoms in different subgroups of the general population. J Nutr. 2017;147(5):879–887. doi:10.3945/jn.116.245167
36. Yan T, Ding X, Xie T, et al. Physical activity (PA) influences the risk of depression associated with long working hours. J Affect Disord. 2023;321:227–233. doi:10.1016/j.jad.2022.10.043
37. Chen L, Cai M, Li H, et al. Risk/benefit tradeoff of habitual physical activity and air pollution on chronic pulmonary obstructive disease: findings from a large prospective cohort study. BMC Med. 2022;20(1):70. doi:10.1186/s12916-022-02274-8
38. Ran J, Zhang Y, Han L, et al. The joint association of physical activity and fine particulate matter exposure with incident dementia in elderly Hong Kong residents. Environ Int. 2021;156:106645. doi:10.1016/j.envint.2021.106645
39. Piercy KL, Troiano RP, Ballard RM, et al. The physical activity guidelines for Americans. JAMA. 2018;320(19):2020–2028. doi:10.1001/jama.2018.14854
40. Dong L, Xie Y, Zou X. Association between sleep duration and depression in US adults: a cross-sectional study. J Affect Disord. 2022;296:183–188. doi:10.1016/j.jad.2021.09.075
41. Liu X, Liu X, Wang Y, et al. Association between depression and oxidative balance score: national health and nutrition examination survey (NHANES) 2005-2018. J Affect Disord. 2023;337:57–65. doi:10.1016/j.jad.2023.05.071
42. Kaufmann CN, Spira AP, Depp CA, Mojtabai R. Long-term use of benzodiazepines and non-benzodiazepine hypnotics from 1999 to 2014: results from the national health and nutrition examination survey. Psychiatr Serv. 2018;69(2):235–238. doi:10.1176/appi.ps.201700095
43. Chan WS, Lam SCY, Ng ASY, Lobo S. Daily associations of sleep quality and sleep duration with anxiety in young adults: the moderating effect of alexithymia. Behav Sleep Med. 2022;20(6):787–797. doi:10.1080/15402002.2021.2016406
44. Ogawa S, Kitagawa Y, Fukushima M, et al. Interactive effect of sleep duration and physical activity on anxiety/depression in adolescents. Psychiatry Res. 2019;273:456–460. doi:10.1016/j.psychres.2018.12.085
45. Zhang Y, Zhang Y, Deng R, et al. Association of sleep duration and screen time with anxiety of pregnant women during the COVID-19 pandemic. Front Psychol. 2021;12:646368. doi:10.3389/fpsyg.2021.646368
46. Krause AJ, Simon EB, Mander BA, et al. The sleep-deprived human brain. Nat Rev Neurosci. 2017;18(7):404–418. doi:10.1038/nrn.2017.55
47. Yoo -S-S, Gujar N, Hu P, Jolesz FA, Walker MP. The human emotional brain without sleep--a prefrontal amygdala disconnect. Curr Biol. 2007;17(20):R877–878. doi:10.1016/j.cub.2007.08.007
48. Killgore WDS. Self-reported sleep correlates with prefrontal-amygdala functional connectivity and emotional functioning. Sleep. 2013;36(11):1597–1608. doi:10.5665/sleep.3106
49. Motomura Y, Kitamura S, Oba K, et al. Sleep debt elicits negative emotional reaction through diminished amygdala-anterior cingulate functional connectivity. PLoS One. 2013;8(2):e56578. doi:10.1371/journal.pone.0056578
50. D’Aurea C, Poyares D, Piovezan RD, et al. Objective short sleep duration is associated with the activity of the hypothalamic-pituitary-adrenal axis in insomnia. Arq Neuropsiquiatr. 2015;73(6):516–519. doi:10.1590/0004-282X20150053
51. Chan II, Wu AMS. Assessing the role of cortisol in anxiety, major depression, and neuroticism: a Mendelian randomization study using SERPINA6/SERPINA1 variants. Biological Psychiatry: Global Open Science. 2024;4:100294.
52. Irwin MR. Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol. 2015;66(1):143–172. doi:10.1146/annurev-psych-010213-115205
53. Won E, Kim Y-K. Neuroinflammation-associated alterations of the brain as potential neural biomarkers in anxiety disorders. Int J Mol Sci. 2020;21(18):6546. doi:10.3390/ijms21186546
54. Prather AA, Vogelzangs N, Penninx BWJH. Sleep duration, insomnia, and markers of systemic inflammation: results from the Netherlands study of depression and anxiety (NESDA). J Psychiatr Res. 2015;60:95–102. doi:10.1016/j.jpsychires.2014.09.018
55. Ye Z, Kappelmann N, Moser S, et al. Role of inflammation in depression and anxiety: tests for disorder specificity, linearity and potential causality of association in the UK Biobank. EClinicalMedicine. 2021;38:100992. doi:10.1016/j.eclinm.2021.100992
56. Killgore WDS. Effects of sleep deprivation on cognition. Prog Brain Res. 2010;185:105–129.
57. Kassaw K, Astatke M. Gender, academic self-efficacy, and goal orientation as predictors of academic achievement. Global J Human-Social Sci. 2017;17:63–73.
58. Cote KA, McCormick CM, Geniole SN, Renn RP, MacAulay SD. Sleep deprivation lowers reactive aggression and testosterone in men. Biol Psychol. 2013;92(2):249–256. doi:10.1016/j.biopsycho.2012.09.011
59. Patel P, Shiff B, Kohn TP, Ramasamy R. Impaired sleep is associated with low testosterone in US adult males: results from the national health and nutrition examination survey. World J Urol. 2019;37(7):1449–1453. doi:10.1007/s00345-018-2485-2
60. Aydogan U, Aydogdu A, Akbulut H, et al. Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocr J. 2012;59(12):1099–1105. doi:10.1507/endocrj.EJ12-0134
61. Zitzmann M. Testosterone, mood, behaviour and quality of life. Andrology. 2020;8(6):1598–1605. doi:10.1111/andr.12867
62. Varga AW, Ducca EL, Kishi A, et al. Effects of aging on slow wave sleep dynamics and human spatial navigational memory consolidation. Neurobiol Aging. 2016;42:142–149. doi:10.1016/j.neurobiolaging.2016.03.008
63. Tatineny P, Shafi F, Gohar A, Bhat A. Sleep in the elderly. Mo Med. 2020;117(5):490–495.
64. Moraes W, Piovezan R, Poyares D, et al. Effects of aging on sleep structure throughout adulthood: a population-based study. Sleep Med. 2014;15(4):401–409. doi:10.1016/j.sleep.2013.11.791
65. Glosemeyer RW, Diekelmann S, Cassel W, et al. Selective suppression of rapid eye movement sleep increases next-day negative affect and amygdala responses to social exclusion. Sci Rep. 2020;10(1):17325. doi:10.1038/s41598-020-74169-8
66. Chen Y, Hicks A, While AE. Loneliness and social support of older people in China: a systematic literature review. Health Soc Care Community. 2014;22(2):113–123. doi:10.1111/hsc.12051
67. Liu L, Gou Z, Zuo J. Social support mediates loneliness and depression in elderly people. J Health Psychol. 2016;21(5):750–758. doi:10.1177/1359105314536941
68. Bakour C, Schwartz S, O’Rourke K, et al. Sleep duration trajectories and systemic inflammation in young adults: results from the national longitudinal study of adolescent to adult health (add health). Sleep. 2017;40(11):zsx156. doi:10.1093/sleep/zsx156
69. Piber D, Olmstead R, Cho JH-J, et al. Inflammaging: age and systemic, cellular, and nuclear inflammatory biology in older adults. J Gerontol a Biol Sci Med Sci. 2019;74(11):1716–1724. doi:10.1093/gerona/glz130
70. Klerman EB, Dijk D-J. Age-related reduction in the maximal capacity for sleep--implications for insomnia. Curr Biol. 2008;18(15):1118–1123. doi:10.1016/j.cub.2008.06.047
71. Jean-Louis G, Shochat T, Youngstedt SD, et al. Age-associated differences in sleep duration in the US population: potential effects of disease burden. Sleep Med. 2021;87:168–173. doi:10.1016/j.sleep.2021.09.004
72. Ohayon MM, Vecchierini M-F. Normative sleep data, cognitive function and daily living activities in older adults in the community. Sleep. 2005;28(8):981–989.
73. Grandner MA, Williams NJ, Knutson KL, Roberts D, Jean-Louis G. Sleep disparity, race/ethnicity, and socioeconomic position. Sleep Med. 2016;18:7–18. doi:10.1016/j.sleep.2015.01.020
74. Yip T, Cheon YM, Wang Y, et al. Racial Disparities in Sleep: associations With Discrimination Among Ethnic/Racial Minority Adolescents. Child Dev. 2020;91(3):914–931. doi:10.1111/cdev.13234
75. Li Q, Douglas JA, Subica AM. Examining neighbourhood-level disparities in Black, Latina/o, Asian, and White physical health, mental health, chronic conditions, and social disadvantage in California. Glob Public Health. 2023;18(1):2273425. doi:10.1080/17441692.2023.2273425
76. Philp L, Alimena S, Sullivan M, et al. Black and hispanic women have less support during cancer evaluation and treatment: results from a prospective patient reported outcomes program in gynecologic malignancy. Int J Gynecol Cancer. 2023;33(5):770–777. doi:10.1136/ijgc-2022-004113
77. Kamara J. Decomposing the wage gap: analysis of the wage gap between racial and ethnic minorities and whites. Pepperdine Policy Rev. 2015;8:1.
78. Moberly T. Doctors from ethnic minority backgrounds earn less than white colleagues. BMJ. 2018;363:k5089. doi:10.1136/bmj.k5089
79. Wickrama KA, Klopack ET, O’Neal CW. Stressful family contexts and health in divorced and married mothers: biopsychosocial process. J Soc Pers Relat. 2022;39(11):3436–3457. doi:10.1177/02654075221098627
80. Richmond RC, Howe LJ, Heilbron K, et al. Correlations in sleeping patterns and circadian preference between spouses. Commun Biol. 2023;6(1):1–14. doi:10.1038/s42003-023-05521-7
81. Troxel WM, Robles TF, Hall M, Buysse DJ. Marital quality and the marital bed: examining the covariation between relationship quality and sleep. Sleep Med Rev. 2007;11(5):389–404. doi:10.1016/j.smrv.2007.05.002
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles

The Effects of Long Working Hours on Mental Health Among Resident Physicians in Saudi Arabia
Bondagji D, Fakeerh M, Alwafi H, Khan AA
Psychology Research and Behavior Management 2022, 15:1545-1557
Published Date: 20 June 2022

Association Between Emotional Eating, Sociodemographic Characteristics, Physical Activity, Sleep Duration, and Mental and Physical Health in Young Adults
Calderón-Asenjo RE, Jalk-Muñoz MC, Calizaya-Milla YE, Calizaya-Milla SE, Ramos-Vera C, Saintila J
Journal of Multidisciplinary Healthcare 2022, 15:2845-2859
Published Date: 13 December 2022

Pre- and Post-Pandemic (COVID-19) Mental Health of International Students: Data from a Longitudinal Study
Jamshaid S, Bahadar N, Jamshed K, Rashid M, Imran Afzal M, Tian L, Umar M, Feng X, Khan I, Zong M
Psychology Research and Behavior Management 2023, 16:431-446
Published Date: 15 February 2023

Prevalence of Internet Addiction and Impact of Internet Socialization on Professional, Academic, Social Lives and Sleep Pattern Among Students and Professionals from Various Fields Across India
Kumar T, Rajendran V, Dutta G, Ambwani S, Lal H, Ram K, Raghav P
Advances in Medical Education and Practice 2023, 14:1369-1378
Published Date: 8 December 2023

AI Technology panic—is AI Dependence Bad for Mental Health? A Cross-Lagged Panel Model and the Mediating Roles of Motivations for AI Use Among Adolescents
Huang S, Lai X, Ke L, Li Y, Wang H, Zhao X, Dai X, Wang Y
Psychology Research and Behavior Management 2024, 17:1087-1102
Published Date: 12 March 2024